A series of 12 consecutive @entity1 who underwent aortic valve replacement (AVR) for @entity472 complicated by severe @entity1002 was reviewed. @entity67 was reflected by @entity891 , @entity4 , @entity8 , and by severely depressed ejection fractions (mean, 13%; range equal to 0-20%). @entity886 was accompanied by mitral commissurotomy in 1 @entity1 and aortocoronary bypass in 5. Three of 5 @entity1 with greater than 50% coronary obstruction died without reversal of @entity712 , and 1 of the 5 died after a @entity64 . The 1 survivor of this group has done well. All 7 @entity1 with minimal or no @entity301 survived operation and are now in New York Heart Association Class I or II. Postoperative catheterization (2 to 12 months) in 6 @entity1 showed improved cardiac index and filling pressures. Left ventricular diastolic volume fell from 159 to 82 ml/m2, and ejection fraction rose from 13 to 45%. We conclude that @entity1002 owing to @entity472 alone is reversible and that AVR results in great clinical improvement. When @entity301 is present, survival may be accompanied by great improvement but the operative mortality is much higher.

Reversal of advanced XXXX following aortic valve replacement for @entity472 .

@entity1 :: ('9606', 'Species') :: ['patients', 'patient'] @entity8 :: ('MESH:D007674', 'Disease') :: ['renal and hepatic dysfunction'] @entity712 :: ('MESH:D006333', 'Disease') :: ['heart failure'] @entity64 :: ('MESH:D020521', 'Disease') :: ['stroke'] @entity67 :: ('MESH:D018754', 'Disease') :: ['Ventricular dysfunction'] @entity301 :: ('MESH:D003327', 'Disease') :: ['coronary disease'] @entity4 :: ('MESH:D004487', 'Disease') :: ['edema'] @entity886 :: ('MESH:C563178', 'Disease') :: ['Aortic valve replacement'] @entity891 :: ('MESH:D001261', 'Disease') :: ['pulmonary congestion'] @entity472 :: ('MESH:D001024', 'Disease') :: ['aortic stenosis'] @entity1002 :: ('MESH:D018487', 'Disease') :: ['left ventricular dysfunction']
@entity1002 :: (MESH:D018487,Disease) :: ['left ventricular dysfunction']
